Daniel Lawrence Cruser
About
Dr. Daniel L. Cruser is a physician specializing in anatomic and clinical pathology, practicing in the Hudson Valley region of New York. His practice address is associated with Keller Army Community Hospital at West Point, and he holds medical licenses in New York, Pennsylvania, New Jersey, and Connecticut.
Dr. Cruser has been an active contributor to research on COVID-19 convalescent plasma therapy, with work appearing in journals including The Lancet Microbe, JCI Insight, Transfusion, and Microbiology Spectrum. His publications address outpatient convalescent plasma trials, transfusion reactions, post-exposure prophylaxis against SARS-CoV-2, and the dynamics of inflammatory responses by vaccination status. Much of this work was conducted within the context of multi-site clinical trials coordinated through hospital blood bank networks. He has also contributed pathology expertise in support of published case studies, including work recognized by colleagues at Vassar Brothers Medical Center.
Credentials
Publications
- Creating a plasma coordination center to support COVID-19 outpatient trials across a national network of hospital blood banks.
- Outpatient COVID-19 convalescent plasma recipient antibody thresholds correlated to reduced hospitalizations within a randomized trial.
- COVID-19 convalescent plasma therapy decreases inflammatory cytokines: a randomized controlled trial.
- Dynamics of inflammatory responses after SARS-CoV-2 infection by vaccination status in the USA: a prospective cohort study.
- Transfusion reactions associated with COVID-19 convalescent plasma in outpatient clinical trials.
- Outpatient COVID-19 convalescent plasma recipient antibody thresholds correlated to reduced hospitalizations within a randomized trial.
- Transfusing Convalescent Plasma as Post-Exposure Prophylaxis Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Double-Blinded, Phase 2 Randomized, Controlled Trial.
- Early Outpatient Treatment for Covid-19 with Convalescent Plasma.
- How do I implement an outpatient program for the administration of convalescent plasma for COVID-19?
- Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent Plasma.
Request CV and rates
Tell us about your case and we'll connect you with Daniel Lawrence Cruser within two business days.
Other experts
Verified specialists available for your case.
